Invasive fungal infections after CD19 chimeric antigen receptor T-cell therapy for B-cell lymphoma: a Lymphoma study association study from the DESCAR-T (Dispositif d’Enregistrement et Suivi des patients traités par CAR-T cells) registry

Despite the low incidence of IFI in B-cell lymphoma patients treated with CD19 CAR T-cell therapy, the high infectious mortality underscore the need for individualized prophylaxis and rapid diagnosis for high-risk patients.

Authors

Institutions

Publication Details

Journal
Clinical Microbiology and Infection
Published
2025-10-16
DOI
https://doi.org/10.1016/j.cmi.2025.10.005
Citations
1
Primary Topic
CAR-T cell therapy research
Type
article
Field-Weighted Citation Impact
1.05

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Invasive fungal infections after CD19 chimeric antigen receptor T-cell therapy for B-cell lymphoma: a Lymphoma study association study from the DESCAR-T (Dispositif d’Enregistrement et Suivi des patients traités par CAR-T cells) registry

Nicolas Gower, Roberta Di Blasi, Jean‐Pierre Gangneux, Roch Houot et al.
1 citations
Clinical Microbiology and Infection
CAR-T cell therapy research
1.05
article

Invasive fungal infections after CD19 chimeric antigen receptor T-cell therapy for B-cell lymphoma: a Lymphoma study association study from the DESCAR-T (Dispositif d’Enregistrement et Suivi des patients traités par CAR-T cells) registry

Nicolas Gower, Roberta Di Blasi, Jean‐Pierre Gangneux, Roch Houot, Blandine Denis, Amélie Bouvier, Amandine Durand, Martin Eloit, François Lemonnier, Giovanna Melica, C. Lorente, Franck Morschhauser, Arnaud Campidelli, Emmanuel Bachy, Olivier Casasnovas, Thomas Gastinne, Cécile Angebault, Jean‐Jacques Tudesq, Fabien Le Bras, Ludovic Gabellier, Christelle Latiere, Rémi Dulery, Magalie Joris, Vivien Dupont
article en
1 citations

Abstract

Despite the low incidence of IFI in B-cell lymphoma patients treated with CD19 CAR T-cell therapy, the high infectious mortality underscore the need for individualized prophylaxis and rapid diagnosis for high-risk patients.

Clinical Microbiology and InfectionVol. 32(2)
Université de Tours (FR), Inserm (FR), Université Paris-Est Créteil (FR), Université de Montpellier (FR), Université de Lille (FR), Institut Gustave Roussy (FR), Saint Louis University Hospital (US), Sorbonne Université (FR), Lille’s Cardiology Hospital (FR), Centre Hospitalier Universitaire de Montpellier (FR), Centre Hospitalier Universitaire de Tours (FR), Centre Hospitalier Universitaire Amiens-Picardie (FR), Centre Hospitalier Régional et Universitaire de Nancy (FR), Hôpital Saint-Antoine (FR), University of Clermont Auvergne (FR), The Lymphoma Academic Research Organisation (FR), Laboratoire de Thermique et Energie de Nantes (FR), Hôpital Lyon Sud (FR), Hôpital Pontchaillou (FR), Centre Hospitalier Universitaire de Clermont-Ferrand (FR), Hôpitaux Universitaires Henri-Mondor (FR), Centre Oscar Lambret (FR), Maison des Sciences sociales et des Humanités de Dijon (FR), Hôpital Saint-Louis (FR), Lymphoma Study Association (FR), Université Gustave Eiffel (FR), Nantes Université (FR)
Pfizer, Gilead Sciences
Openalex Percentile: Top 17%
CAR-T cell therapy research
1.05
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.